Biblio
Targeted therapy with venetoclax and daratumumab as part of HSCT preparative regimen in children with chemorefractory acute myeloid leukemia.: venetoclax and daratumumab as part of HSCT preparative regimen for AD AML. Transplant Cell Ther. 2022.
Allogeneic hematopoietic stem cell transplantation for mature T/NK-cell lymphomas in children. Transplant Cell Ther. 2024.
.